Mandate

Vinge advises Sleep Cycle AB (publ) in connection with the listing on Nasdaq Stockholm

Vinge advises Sleep Cycle AB (publ) (“Sleep Cycle” or the “Company”) in connection with the listing on Nasdaq Stockholm. The offering circular was published on 28 May 2021 and the first day of trading on Nasdaq Stockholm was 8 June 2021.

The offering price was SEK 70 per share, corresponding to a market value of Sleep Cycle of approximately SEK 1.3bn. The offering comprised 4,870,171 shares, of which 1,428,571 are newly issued shares and 3,441,600 are existing shares.

Sleep Cycle is a market leading sleep tracking application with a mission to empower people to sleep better to improve global health. Sleep Cycle uses a patented AI-based audio technology to measure users’ sleep and provide personalized insights based on the Company’s sleep database. Sleep Cycle was founded in 2009 and is headquartered in Gothenburg, Sweden.

Vinge’s team mainly consisted of Jesper Schönbeck, Linnéa Sellström, Joel Magnusson and Lorin Arabi (Capital Markets and Public M&A), Matthias Pannier, Vilhelm Rondahl and Mikaela Falkner (M&A), Victor Ericsson, Henrik Wastenson and Jonathan Riddersholm (Corporate tax), Stojan Arnestål and Felizia Wiker (IP) and Ebba Svenburg (Employment and Benefits).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026